Procalcitonin as a Marker of Serious Bacterial Infections in Febrile Children Younger Than 3 Years Old

Abstract

Procalcitonin is a more accurate biomarker than traditional screening tests for identifying young febrile infants and children with serious SBIs. Further study on a larger cohort of young febrile children is required to definitively determine the benefit of PCT over traditional laboratory screening tests for SBIs.